Retention of Tc-99m ECD in delayed SPECT of the brain

Annals of Nuclear Medicine

Volumn 13, Issue 1, 1999, Pages 1-4

  Flores II, Leo G ^a   Jinnouchi, Seishi ^b   Nagamachi, Shigeki ^b   Ohnishi, Takashi ^b   Futami, Shigemi ^b   Nakahara, Hiroshi ^b   Shimoshinbara, Shigeru ^b   Ushinbana, Kenji ^b   Tamura, Shozo ^b  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NONE

Author keywords

Retention rate; SPECT; Tc 99m ECD

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; BASAL GANGLION; BRAIN REGION; CEREBELLUM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG RETENTION; FEMALE; FRONTAL LOBE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; OCCIPITAL LOBE; PARIETAL LOBE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE; THALAMUS;

EID: 0033012929     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03165420     Document Type: Article

References (15)

1. Moretti JM, Tamgac F, Weinmann P, Caillat-Vigneron N, Belin CA, Cesaro P, et al. Early and delayed brain SPECT with technetium-99m-ECD and iodine-123-IMP in sub-acute strokes. J Nucl Med 35: 1444-1449, 1994.
2. 99mTc-ECD). J Cereb Blood Flow Metab 14: S4-S11, 1994.
3. Ichise M, Golan H, Ballinger JR, Vines D, Blackman A, Moldofsky H. Regional difference in technetium-99m-ECD clearance on the brain SPECT in healthy subjects. J Nucl Med 38: 1253-1260, 1997.
4. 99mTc-L,L-Ethyl cysteinate dimer in healthy volunteers. Neuropharmacology 30: 283-292, 1991.
5. Lévéillé J, Demonceau G, De Roo M, Rigo P, Taillefer R, Morgan RA, et al. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 2: biodistribution and brain imaging in humans. J Nucl Med 30: 1902-1910, 1989.
6. Devous MD Sr, Payne JK, Lowe JL, Leroy RF. Comparison of technetium-99m-ECD to xenon-133 SPECT in normal controls and in patients with mild to moderate regional cerebral blood flow abnormalities. J Nucl Med 34: 754-761, 1993.
7. 99mTc-ECD-multicenter study. KAKU IGAKU (Jpn J Nucl Med) 29: 1113-1125, 1992.
8. 99mTc-ECD. KAKU IGAKU (Jpn J Nucl Med) 28: 701-709, 1991.
9. Jacquier-Sarlin MR, Polla BS, Slosman DO. Cellular basis of ECD brain retention. J Nucl Med 37: 1694-1697, 1996.
10. Inoue Y, Momose T, Ohtake T, Nishikawa J, Sasaki Y, Waritani T, et al. Metabolism of technetium-99m-L,L-ethyl cysteinate dimer in rat and cynomolgus monkey tissue. J Nucl Med 38: 1733-1737, 1997.
11. Koyama M, Kawashima R, Ito H, Ono S, Sato K, Goto R, et al. SPECT imaging of normals subjects with technetium-99m-HMPAO and technetium-99m-ECD. J Nucl Med 38: 587-592, 1997.
12. Shimosegawa E, Hatazawa J, Aizawa Y, Shouji Y, Hachiya T, Murakami M. Technetium-99m-ECD brain SPECT in misery perfusion. J Nucl Med 38: 791-796, 1997.
13. 99mTc-ECD consecutive SPECT method. J Cereb Blood Flow Metab 17: 1020-1032, 1997.
14. Noachtar S, Arnold S, Yousry TA, Bartenstein P, Werhahn KJ, Tatsch K. Ictal technetium-99m ethyl cysteinate dimer single-photon emission tomographic findings and propagation of epileptic seizure activity in patients with extratemporal epilepsies. Eur J Nucl Med 25: 166-172, 1998.
15. 99mTc-bicisate in activation studies by split-dose technique. J Cereb Blood Flow Metab 14: S115-S120, 1994.